Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Non-Current Deffered Revenue (2016 - 2026)

Sensus Healthcare has reported Non-Current Deffered Revenue over the past 11 years, most recently at $10000.0 for Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue fell 81.82% year-over-year to $10000.0; the TTM value through Dec 2025 reached $10000.0, down 81.82%, while the annual FY2025 figure was $10000.0, 81.82% down from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 was $10000.0 at Sensus Healthcare, down from $21000.0 in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $418000.0 in Q1 2021 and troughed at $10000.0 in Q4 2025.
  • A 5-year average of $135950.0 and a median of $98000.0 in 2023 define the central range for Non-Current Deffered Revenue.
  • On a YoY basis, Non-Current Deffered Revenue climbed as much as 7.5% in 2025 and fell as far as 81.82% in 2025.
  • Year by year, Non-Current Deffered Revenue stood at $262000.0 in 2021, then tumbled by 46.95% to $139000.0 in 2022, then crashed by 56.83% to $60000.0 in 2023, then fell by 8.33% to $55000.0 in 2024, then tumbled by 81.82% to $10000.0 in 2025.
  • Business Quant data shows Non-Current Deffered Revenue for SRTS at $10000.0 in Q4 2025, $21000.0 in Q3 2025, and $32000.0 in Q2 2025.